May 8, 2018 / 10:49 PM / 19 days ago

BRIEF-Oncomed Reports Q1 Loss Per Share $0.15

May 8 (Reuters) - OncoMed Pharmaceuticals Inc:

* ONCOMED ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* Q1 REVENUE $7.8 MILLION VERSUS $6.2 MILLION

* CURRENT CASH IS ESTIMATED TO BE SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST Q3 OF 2019

* ONCOMED PHARMACEUTICALS - ESTIMATES 2018 OPERATING CASH BURN TO BE APPROXIMATELY $55 MILLION, BEFORE CONSIDERING POTENTIAL MILESTONE OR OPT-IN PAYMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below